A BILL 
To establish an awareness campaign related to the lethality 
of fentanyl and fentanyl-contaminated drugs, to establish 
a Federal Interagency Work Group on Fentanyl Con-
tamination of Illegal Drugs, and to provide community- 
based coalition enhancement grants to mitigate the ef-
fects of drug use. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as ‘‘Bruce’s Law’’. 
4
00:11 Oct 26, 2022
H9221
2 
•HR 9221 IH
SEC. 2. AWARENESS CAMPAIGNS. 
1
(a) OPIOID PROGRAM.—Section 102 of the Com-
2
prehensive Addiction and Recovery Act of 2016 (Public 
3
Law 114–198) is amended— 
4
(1) in the section heading, by inserting ‘‘RE-
5
LATING TO OPIOIDS’’ after ‘‘CAMPAIGNS’’; and 
6
(2) in subsection (c)— 
7
(A) in paragraph (1), by inserting ‘‘and’’ 
8
after the semicolon; 
9
(B) in paragraph (2)(B), by striking ‘‘; 
10
and’’ and inserting a period; and 
11
(C) by striking paragraph (3). 
12
(b) ADDITIONAL CAMPAIGN.—Title I of the Com-
13
prehensive Addiction and Recovery Act of 2016 (Public 
14
Law 114–198) is amended by inserting after section 102 
15
the following: 
16
‘‘SEC. 
102A. 
AWARENESS 
CAMPAIGN 
RELATED 
TO 
17
LETHALITY OF FENTANYL AND FENTANYL- 
18
CONTAMINATED DRUGS. 
19
‘‘(a) IN GENERAL.—The Secretary of Health and 
20
Human Services, in coordination with the heads of other 
21
Federal departments and agencies, shall, as appropriate, 
22
through a public awareness campaign, advance the edu-
23
cation and awareness of the public (including school-aged 
24
children, youth, parents, first responders, and providers) 
25
and other appropriate entities regarding the risk of coun-
26
00:11 Oct 26, 2022
H9221
3 
•HR 9221 IH
terfeit drugs being contaminated with fentanyl or other 
1
synthetic opioids and the lethality and other dangers of 
2
synthetic opioids. 
3
‘‘(b) TOPICS.—The education and awareness cam-
4
paigns under subsection (a) shall address— 
5
‘‘(1) the dangers of using drugs which may be 
6
contaminated with fentanyl or other synthetic 
7
opioids; 
8
‘‘(2) the prevention of substance use disorder 
9
and use of drugs other than as prescribed, including 
10
through safe disposal of prescription medications 
11
and other safety precautions; and 
12
‘‘(3) the detection of early warning signs of 
13
substance use disorder and addiction in school-aged 
14
children and youth. 
15
‘‘(c) OTHER REQUIREMENTS.—The education and 
16
awareness campaigns under subsection (a) shall, as appro-
17
priate, take into account any association between the use 
18
of prescription drugs other than as prescribed and the use 
19
of drugs that can be contaminated by fentanyl or other 
20
opioids, including heroin. 
21
‘‘(d) DRUG DEFINED.—In this section, the term 
22
‘drug’ means an illicit drug, such as marijuana, hashish, 
23
cocaine 
(including 
crack 
cocaine), 
inhalants, 
24
hallucinogens, heroin, a synthetic opioid, methamphet-
25
00:11 Oct 26, 2022
H9221
4 
•HR 9221 IH
amine or other stimulant, a counterfeit prescription drug, 
1
or a prescription drug that is sold illegally. 
2
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There 
3
are authorized to be appropriated for fiscal years 2023 
4
through 2027 such sums as may be necessary to carry 
5
out this section.’’. 
6
SEC. 
3. 
FEDERAL 
INTERAGENCY 
WORK 
GROUP 
ON 
7
FENTANYL 
CONTAMINATION 
OF 
ILLEGAL 
8
DRUGS. 
9
Title I of the Comprehensive Addiction and Recovery 
10
Act of 2016 (Public Law 114–198), as amended by section 
11
2(b), is further amended by inserting after section 102A 
12
the following: 
13
‘‘SEC. 102B. FEDERAL INTERAGENCY WORK GROUP ON 
14
FENTANYL 
CONTAMINATION 
OF 
ILLEGAL 
15
DRUGS. 
16
‘‘(a) ESTABLISHMENT.—The Secretary of Health 
17
and Human Services (referred to in this section as the 
18
‘Secretary’) shall establish the Federal Interagency Work 
19
Group on Fentanyl Contamination of Illegal Drugs (re-
20
ferred to in this section as the ‘Work Group’). 
21
‘‘(b) MEMBERSHIP; CONSULTATION.— 
22
‘‘(1) COMPOSITION.—Not later than 120 days 
23
after the date of enactment of Bruce’s Law, the 
24
heads of the Office of National Drug Control Policy, 
25
00:11 Oct 26, 2022
H9221
5 
•HR 9221 IH
the Substance Abuse and Mental Health Services 
1
Administration, the Administration for Children and 
2
Families, the Centers for Disease Control and Pre-
3
vention, the Department of Justice, the Drug En-
4
forcement Administration, the Department of State, 
5
the Department of Education, and other Federal 
6
agencies (as determined by the Secretary) shall des-
7
ignate representatives of the respective agency or of-
8
fice to the Work Group. 
9
‘‘(2) CONSULTATION.—The Work Group shall 
10
consult with— 
11
‘‘(A) experts at the State, Tribal, and local 
12
levels with relevant backgrounds in reducing, 
13
preventing, and responding to drug overdose by 
14
fentanyl contamination of illegal drugs; 
15
‘‘(B) individuals in recovery from use of 
16
fentanyl other than as prescribed or use of 
17
other synthetic opioids; 
18
‘‘(C) family members of adults who have 
19
overdosed 
by 
fentanyl-contaminated 
illegal 
20
drugs; 
21
‘‘(D) family members of school-aged chil-
22
dren and youth who have overdosed by fentanyl- 
23
contaminated illegal drugs; 
24
00:11 Oct 26, 2022
H9221
6 
•HR 9221 IH
‘‘(E) researchers and other experts in the 
1
design and implementation of effective drug-re-
2
lated messaging and prevention campaigns; and 
3
‘‘(F) technology companies. 
4
‘‘(c) DUTIES.—The Work Group shall— 
5
‘‘(1) examine all Federal efforts directed to-
6
wards reducing and preventing drug overdose by 
7
fentanyl- or other synthetic opioid-contaminated ille-
8
gal drugs; 
9
‘‘(2) identify strategies, resources, and supports 
10
to improve State, Tribal, and local responses to over-
11
dose by fentanyl- or other synthetic opioid-contami-
12
nated illegal drugs; 
13
‘‘(3) make recommendations to Congress for 
14
improving Federal programs and efforts and coordi-
15
nation across such programs and efforts to reduce 
16
and prevent drug overdose by fentanyl- or other syn-
17
thetic opioid-contaminated illegal drugs; and 
18
‘‘(4) make recommendations for educating 
19
youth on the dangers of drugs contaminated by 
20
fentanyl or other synthetic opioids. 
21
‘‘(d) ANNUAL REPORT TO SECRETARY.—The Work 
22
Group shall annually prepare and submit to the Secretary, 
23
the Committee on Health, Education, Labor, and Pen-
24
sions of the Senate, and the Committee on Education and 
25
00:11 Oct 26, 2022
H9221
7 
•HR 9221 IH
Labor and the Committee on Energy and Commerce of 
1
the House of Representatives, a report on the activities 
2
carried out by the Work Group under subsection (c), in-
3
cluding recommendations to reduce and prevent drug over-
4
dose by fentanyl or other synthetic opioid contamination 
5
of illegal drugs, in all populations, and specifically among 
6
youth at risk for substance use disorder and use of drugs 
7
other than as prescribed.’’. 
8
SEC. 4. COMMUNITY-BASED COALITION ENHANCEMENT 
9
GRANTS TO ADDRESS LOCAL DRUG CRISES. 
10
Section 103(i) of the Comprehensive Addiction and 
11
Recovery Act of 2016 (21 U.S.C. 1536(i)) is amended by 
12
striking ‘‘2017 through 2021’’ and inserting ‘‘2023 
13
through 2027’’. 
14
SEC. 5. COMMUNITY-BASED COALITION ENHANCEMENT 
15
GRANTS TO EDUCATE YOUTH ON THE RISKS 
16
OF DRUGS CONTAMINATED WITH FENTANYL 
17
OR OTHER SYNTHETIC OPIOIDS. 
18
Title I of the Comprehensive Addiction and Recovery 
19
Act of 2016 (Public Law 114–198) is amended by insert-
20
ing after section 103 the following: 
21
00:11 Oct 26, 2022
H9221
8 
•HR 9221 IH
‘‘SEC. 103A. COMMUNITY-BASED COALITION ENHANCEMENT 
1
GRANTS TO EDUCATE YOUTH ON THE RISKS 
2
OF DRUGS CONTAMINATED WITH FENTANYL 
3
OR OTHER SYNTHETIC OPIOIDS. 
4
‘‘(a) PROGRAM AUTHORIZED.—The Director of the 
5
Office of National Drug Control Policy (referred to in this 
6
section as the ‘Director’), in coordination with the Direc-
7
tor of the Centers for Disease Control and Prevention, 
8
may make grants to eligible entities to implement edu-
9
cation of the public on the dangers of contamination of 
10
drugs with fentanyl or other synthetic opioids. 
11
‘‘(b) APPLICATION.— 
12
‘‘(1) IN GENERAL.—An eligible entity seeking a 
13
grant under this section shall submit an application 
14
to the Director at such time, in such manner, and 
15
accompanied by such information as the Director 
16
may require. 
17
‘‘(2) CRITERIA.—As part of an application for 
18
a grant under this section, the Director shall require 
19
an eligible entity to submit a detailed, comprehen-
20
sive, multisector plan for addressing the implementa-
21
tion of an evidence-based public education campaign 
22
on the dangers of drugs contaminated with fentanyl 
23
or other synthetic opioids, with a specific consider-
24
ation given to education focused on youth at in-
25
creased risk for developing a substance use disorder. 
26
00:11 Oct 26, 2022
H9221
9 
•HR 9221 IH
‘‘(3) ELIGIBLE ENTITIES.—For purposes of this 
1
section, the term ‘eligible entity’ means an entity 
2
that— 
3
‘‘(A) has documented, using local data, 
4
rates of drug overdose related to fentanyl or 
5
other synthetic opioids at levels that are signifi-
6
cant, as determined by the Director; and 
7
‘‘(B) has received a grant under the Drug- 
8
Free Communities Act of 1997. 
9
‘‘(c) USE OF FUNDS.—An eligible entity shall use a 
10
grant received under this section— 
11
‘‘(1) for programs designed to implement com-
12
prehensive community-wide prevention strategies to 
13
address the dangers of drugs contaminated with 
14
fentanyl or other synthetic opioids, in the area 
15
served by the eligible entity, in accordance with the 
16
plan submitted under subsection (b)(2); 
17
‘‘(2) to obtain specialized training and technical 
18
assistance from the organization funded under sec-
19
tion 4 of Public Law 107–82 (21 U.S.C. 1521 note); 
20
and 
21
‘‘(3) for programs designed to implement com-
22
prehensive community-wide strategies to address the 
23
dangers of drugs contaminated with fentanyl or 
24
other synthetic opioids in the community. 
25
00:11 Oct 26, 2022
H9221
10 
•HR 9221 IH
‘‘(d) SUPPLEMENT NOT SUPPLANT.—An eligible en-
1
tity shall use Federal funds received under this section 
2
only to supplement the funds that would, in the absence 
3
of those Federal funds, be made available from other Fed-
4
eral and non-Federal sources for the activities described 
5
in this section, and not to supplant those funds. 
6
‘‘(e) EVALUATION.—A grant under this section shall 
7
be subject to the same evaluation requirements and proce-
8
dures as the evaluation requirements and procedures im-
9
posed on the recipient of a grant under the Drug-Free 
10
Communities Act of 1997, and shall also include an eval-
11
uation of the effectiveness at reducing the use of illicit 
12
fentanyl or other synthetic opioids. 
13
‘‘(f) LIMITATION ON ADMINISTRATIVE EXPENSES.— 
14
Not more than 12 percent of the amounts made available 
15
to carry out this section for a fiscal year may be used 
16
to pay for administrative expenses. 
17
‘‘(g) DELEGATION AUTHORITY.—The Director may 
18
enter into an interagency agreement with the Director of 
19
the Centers for Disease Control and Prevention to dele-
20
gate authority for the execution of grants and for such 
21
other activities, as the Director determines necessary to 
22
carry out this section. 
23
‘‘(h) DEFINITION.—In this section, the term ‘drug’ 
24
means an illicit drug, such as marijuana, hashish, cocaine 
25
00:11 Oct 26, 2022
H9221
11 
•HR 9221 IH
(including crack cocaine), inhalants, hallucinogens, heroin, 
1
a synthetic opioid, methamphetamine or other stimulant, 
2
a counterfeit prescription drug, or a prescription drug that 
3
is sold illegally. 
4
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—For the 
5
purpose of carrying out this section, there are authorized 
6
to be appropriated such sums as may be necessary for 
7
each of fiscal years 2023 through 2027.’’. 
8
Æ 
00:11 Oct 26, 2022
H9221
